Medical device company Philips reached a settlement Monday to shell out $1.1 billion to cover hundreds of personal injury lawsuits linked to its respiration and sleep apnea machines. The ...

The Food and Drug Administration has labeled a recall of Philips’ Tack Endovascular Systems as a Class l, which is the most serious kind of recall. There have been 20 reported injuries and no ...

Philips is recalling the Tack endovascular system because of what it says are user challenges that have led to additional interventions needed to retrieve or remove the implant. The US Food and Drug ...

Philips will no longer sell its Tack endovascular system in the US following a Class I recall by the US Food and Drug Administration (FDA). Class I is the most serious designation for a recall ...

Philips is pulling from the market an implant designed to help repair the interior of damaged blood vessels following a serious product recall. The company’s Tack endovascular system includes a ...

Exor NV , the investment arm of Italy's Agnelli family, has increased its stake in health technology company Philips to 18.7% ...

During its first-quarter earnings report this spring, Philips, the health technology company, announced it agreed to pay $1.1 billion in a settlement over respiration and sleep apnea machines.

Italy's billionaire Agnelli family has taken a 15% stake in Dutch electronics company Royal Philips, in what is being viewed as a much-needed vote of confidence in its decision to switch its focus ...